Publications<< Back

Massot A, Vivanco R, Principe A, Roquer J, Rocamora R

Post-authorisation study of eslicarbazepine as treatment for drug-resistant epilepsy: preliminary results.

Neurologia. 2014 Mar;29(2):94-101, PMID: 23623701

Eslicarbazepine acetate (ESL) is a new antiepileptic drug (AED) and an analogue to carbamazepine (CBZ) and oxcarbazepine (OXC). In this study, we evaluate initial therapeutic response to ESL and events in the change from CBZ and OXC.


Download publication

An initiative of

Ministerio de Economía y Competitividad Fondo Europeo de Desarrollo Regional IMIM - Parc de Salut Mar